Decompensated Cirrhosis Clinical Trials

57 clinical trials for Decompensated Cirrhosis across international registries, including 9 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Hospital @ Home Model of Care for Cirrhosis — RECRUITING · NA
• Fecal Microbiome Transplantation in Cirrhosis: Trial in Patients With Decompensated Cirrhosis — RECRUITING · PHASE3
• Trial Comparing Conventional Antibiotic Strategies Versus Regimens Guided by Epidemiological Surveillance in Infected Patients With Cirrhosis (SURVIC_STUDY) — RECRUITING · PHASE4
• CirrhoCare- Using Smart-phone Technology to Enhance Care and Access to Treatment for Cirrhosis — RECRUITING · NA
• HCL001 Cell Injection for Decompensated Cirrhosis: A Phase I/II Trial — RECRUITING · PHASE1
• RTX001 Autologous Engineered Macrophages for Liver Cirrhosis — RECRUITING · PHASE1
• BCAA vs. Rifaximin in Patients With Cirrhosis for Secondary Prophylaxis of HE — RECRUITING · PHASE4
• Carvedilol + Simvastatin vs. Carvedilol Alone for Cirrhosis and Cirrhotic Cardiomyopathy and Impact on Hepatic Decompensation and Survival — RECRUITING · NA
• Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-2) — RECRUITING · PHASE2
• Safety and efficacy of a human albumin solution with restored structural profile in patients with decompensated cirrhosis — TERMINATED · PHASE2
• New Prognostic Predictive Models of Mortality of Decompensated Cirrhotic Patients Waiting for Liver Transplantation — COMPLETED · NA
• A Study to See if an Investigational Medicine Called VS-01 Can Help and How Safe it is in the Treatment of Patients With Overt Hepatic Encephalopathy — TERMINATED · PHASE2
• Study to Evaluate the Efficacy of Intravenous Administration of Human Albumin Versus Saline Solution in Patients With descompénsate Cirrhosis Grade 1B or Higher Renal Failure — NOT_YET_RECRUITING · PHASE4
• National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Single vs Repeated Cycle of Granulocyte Colony-Stimulating Factor (GCSF) & Darbepoetin in Early Decompensated Cirrhosis — NOT_YET_RECRUITING · NA
• A Study to Predict Recompensation in Patients With Decompensated Cirrhosis Using Spleen Stiffness and Simple Blood Tests — NOT_YET_RECRUITING
• Coagulation Parameters With Albumin in Decompensated Cirrhosis (CoPA-D). — COMPLETED · NA
• Fecal Microbiome Transplantation in Cirrhosis. Randomized, Double-blinded, Placebo-Controlled trial in patients with decompensated cirrhosis. — TERMINATED · PHASE3
• Effect of Albumin Infusion on Oxidative Albumin Modification, Albumin Binding Capacity and Plasma Thiol Status — COMPLETED
• Replicor Compassionate Access Program — TERMINATED
• A Study for Evaluation of BIV201 to Reduce Ascites and Complications in Patients With Cirrhosis and Refractory Ascites — TERMINATED · PHASE2
• Prospective Cohort Study of Complications and Outcomes in Cirrhosis — OTHER
• Effect of IMO on Intestinal Microbiota Translocation in Cirrhosis — OTHER · NA
• Incidence & Predictive Factors of Recompensation in Children With Decompensated Cirrhosis as Per the Baveno VII Criteria — OTHER
• Efficacy of Combination of Midodrine With Propranolol in Preventing First Bleed in Decompensated Cirrhotics With Severe Ascites. — COMPLETED · NA
• Rotational Thromboelastometry Versus Conventional Haemostatic Tests in Children With Decompensated Cirrhosis Undergoing Invasive Procedures. — OTHER · NA
• A Clinical Trial Evaluating the Safety, Tolerability, and Preliminary Efficacy of HCL001 Cell Injection (Homologous Allogeneic Hepatocytes) in Patients With Decompensated Cirrhosis — NOT_YET_RECRUITING · NA
• Evaluation of Low-dose Albumin and Midodrine Versus Midodrine Alone in Outcome of Recurrent Ascites in Patients With Decompensated Cirrhosis. — OTHER · NA
• To Compare the Safety and Efficacy of Dapagliflozin Plus Metformin Versus Sitagliptin Plus Metformin for Treatment of Diabetes in Patients With Compensated and Stable Decompensated Cirrhosis — OTHER · NA
• Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-1b) — OTHER · PHASE1
• Rifaximin for Preventing Progression and Complications in Patients With Decompensated Liver Cirrhosis — OTHER · NA
• Efficacy of High Dose Albumin Therapy in Improving Liver Transplant-free Survival in Patients With Acute Decompensation of Cirrhosis — OTHER
• Immune Profile, Neuronal Dysfunction, Metabolomics and Ammonia in Therapeutic Response of HE in ACLF — OTHER
• Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-1) — OTHER · PHASE1
• Albumin Infusion in Inpatients With Decompensated Cirrhosis — OTHER
• Primary Prophylaxis for Spontaneous Bacterial Peritonitis — TERMINATED · PHASE2
• Companion Protocol for Methacetin Breath Test (MBT) in Conatus Protocol IDN-6556-17 — TERMINATED
• Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis — OTHER · PHASE2
• Re-compensation and Its Clinical Characteristics in HBV Decompensated Cirrhosis — OTHER
• CirrhoCare in COVID-19: A Pilot, Remote, Home Monitoring Study in Advanced Cirrhosis — OTHER
• Avatrombopag in Patients With End-stage Liver Disease and Thrombocytopenia — OTHER · PHASE4
• Efficacy of Targeted And Response-Guided Albumin Therapy Versus Standard Medical Treatment In Outcomes Of Recurrent Ascites In Patients With Decompensated Cirrhosis. — OTHER · NA
• Prospective Cohort Study of Disease and Outcomes in Cirrhosis — OTHER
• Effect of Liver MSCs in Blood of Patients With Liver Disease. — COMPLETED
• Injectable Collagen Scaffold™ Combined With HUC-MSCs Transplantation for Patients With Decompensated Cirrhosis — OTHER · PHASE1
• Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis — OTHER · PHASE2
• Early TIPS With Polytetrafluoroethylene (PTFE) Covered Stents for Acute Variceal Bleeding in Patients With Advanced Cirrhosis — COMPLETED · NA
• Management of Decompensated HCV Cirrhotic Patients — COMPLETED · NA
• A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis — COMPLETED · PHASE3
• To Study The Incidence And Outcome Of Paracentesis Induced Circulatory Dysfunction in Decompensated Cirrhotics Undergoing Less Than 5 Litres Of Ascitic Fluid Tap With Or Without Albumin Infusion. — COMPLETED · NA
• Transjugular Intrahepatic Portosystemic Shunt (TIPS) for Prevention of Variceal Rebleeding in Cirrhotic Patients With Portal Vein Thrombosis — COMPLETED · NA

Refine this search